BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8528105)

  • 1. Quantitative and qualitative comparative analysis of gradient-separated hematopoietic cells from cord blood and chemotherapy-mobilized peripheral blood.
    Sato J; Kawano Y; Takaue Y; Hirao A; Makimoto A; Okamoto Y; Abe T; Shimokawa T; Iwai A; Kuroda Y
    Stem Cells; 1995 Sep; 13(5):548-55. PubMed ID: 8528105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.
    Almici C; Carlo-Stella C; Mangoni L; Garau D; Cottafavi L; Ventura A; Armanetti M; Wagner JE; Rizzoli V
    Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood.
    Abe T; Ito M; Okamoto Y; Kim HJ; Takaue Y; Yasutomo K; Makimoto A; Yamaue T; Kawano Y; Watanabe T; Shimada T; Kuroda Y
    Exp Hematol; 1997 Aug; 25(9):966-71. PubMed ID: 9257810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S; Kawano Y; Watanabe T; Nakagawa R; Suzuya H; Onishi T; Yamazaki J; Nakayama T; Kuroda Y; Takaue Y
    Stem Cells; 2000; 18(3):190-5. PubMed ID: 10840072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.
    Georgiou GM; Roberton DM; Ellis WM; Shen BJ; Ekert H; Hosking CS
    Clin Exp Immunol; 1983 Aug; 53(2):491-6. PubMed ID: 6309446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal processing of human umbilical cord blood for clinical banking.
    Denning-Kendall P; Donaldson C; Nicol A; Bradley B; Hows J
    Exp Hematol; 1996 Oct; 24(12):1394-401. PubMed ID: 8913285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is in vitro expansion of human cord blood cells clinically relevant?
    Denning-Kendall PA; Nicol A; Horsley H; Donaldson C; Bradley B; Hows JM
    Bone Marrow Transplant; 1998 Feb; 21(3):225-32. PubMed ID: 9489644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood.
    Yurasov SV; Flasshove M; Rafii S; Moore MA
    Bone Marrow Transplant; 1996 Apr; 17(4):517-25. PubMed ID: 8722348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R; Van Riet I; Damiaens S; Flament J; Lacor P; Staelens Y; Steenssens L; van Camp B; De Waele M
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
    Kwekkeboom J; Buurman DE; Ploemacher RE; Baars JW; Loos HA; Slaper-Cortenbach IC
    Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A; Xu G; Constantinescu D; Kashiwakura I; Farley T; Dobrila L; Rubinstein P; Adamson JW
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
    de Wynter EA; Coutinho LH; Pei X; Marsh JC; Hows J; Luft T; Testa NG
    Stem Cells; 1995 Sep; 13(5):524-32. PubMed ID: 8528102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
    Benboubker L; Domenech J; Linassier C; Desbois I; Delain M; Lamagnere JP; Colombat P; Binet C
    Exp Hematol; 1995 Dec; 23(14):1568-73. PubMed ID: 8542948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].
    Ma Y; Zou P; Xiao J; Huang S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):330-3. PubMed ID: 11953192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.